Inhibition of STMN1 expression in a prostate cancer cell line DU-145, a standard prostate cancer cell line used for CSC enrichment [68], accelerated the metastatic process by initiating an EMT program via activation of p38 and cooperation of TGF-β signaling [42]. The gene discussed is STMN1; the disease is prostate cancer.